Literature DB >> 27863842

Development of T follicular helper cells and their role in disease and immune system.

Sadegh Eivazi1, Salman Bagheri2, Mohammad Sadegh Hashemzadeh3, Majdedin Ghalavand3, Elmira Safaie Qamsari2, Ruhollah Dorostkar4, Maryam Yasemi5.   

Abstract

The T follicular helper cells (TFH) are a subset of CD4+ T cells specialized to regulate antibody responses. The production of these cells is associated with the dendritic cells (DCs) and B cells. TFH cells help B cells form germinal centers (GC) differentiate into memory and plasma cells (antibody-secreting cells) as humoral responses. In addition, there is strong evidence that TFH cells play a pivotal role in the development of long-lived humoral immunity. Molecular factors such as transcription factors, surface receptors, cytokine and micro RNAs are involved in the formation of TFH cells. Such TFH cells are diagnosed by transcription factor (BCL-6), surface marker expression (including CXCR5, PD-1, ICOS and CD40L) and a unique cytokine production pattern (such as IL-21 and IL-6). Memory TFH cells, accompanied by memory B cells, are known to be formed during antibody responses. It is now clear that the precise control of TFH cells is critically important for both inducing the optimal affinity maturation of antibody responses and preventing self-reactivity. Exclusive controls of TFH cell function and production are essential for human health. However, it is important to note that excessive activities may lead to autoimmune diseases, while reduced activity often results in immunodeficiency. It has also been shown that TFH cells are associated with cancers such as angioimmunoblastic T-cell lymphoma (AITL), follicular T-cell lymphoma (FTCL) and nonspecific Peripheral T-cell lymphomas (PTCLs). The biology of TFH cells, including their differentiation and transcriptional regulation will be described in the present review. Some of The developments of these cells in immunodeficiency diseases, autoimmunity and cancer will also be taken into account.
Copyright © 2016. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Autoimmune diseases; Cancer; Cytokine; Immunodeficiency; T cell; TFH cell

Mesh:

Year:  2016        PMID: 27863842     DOI: 10.1016/j.biopha.2016.10.083

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  19 in total

1.  Characterization of circulating and cultured Tfh-like cells in sickle cell disease in relation to red blood cell alloimmunization status.

Authors:  Raisa Balbuena-Merle; Manjula Santhanakrishnan; Lesley Devine; David R Gibb; Christopher A Tormey; Alexa J Siddon; Susanna A Curtis; Patrick G Gallagher; Jason S Weinstein; Jeanne E Hendrickson
Journal:  Transfus Apher Sci       Date:  2020-04-27       Impact factor: 1.764

2.  Exploiting Pre-Existing CD4+ T Cell Help from Bacille Calmette-Guérin Vaccination to Improve Antiviral Antibody Responses.

Authors:  Tony W Ng; Ariel S Wirchnianski; Anna Z Wec; J Maximilian Fels; Christopher T Johndrow; Kevin O Saunders; Hua-Xin Liao; John Chan; William R Jacobs; Kartik Chandran; Steven A Porcelli
Journal:  J Immunol       Date:  2020-06-08       Impact factor: 5.422

3.  γδTFH cells promote B cell maturation and antibody production in neuroblastoma.

Authors:  Wenjun Mou; Wei Han; Xiaoli Ma; Xiaolin Wang; Hong Qin; Wen Zhao; Xiaoya Ren; Xi Chen; Wei Yang; Haiyan Cheng; Xisi Wang; Hui Zhang; Xin Ni; Huanmin Wang; Jingang Gui
Journal:  BMC Immunol       Date:  2017-07-07       Impact factor: 3.615

4.  Increased CCR7loPD-1hiCXCR5+CD4+ T Cells in Peripheral Blood Mononuclear Cells Are Correlated with Immune Activation in Patients with Chronic HBV Infection.

Authors:  Ya-Xin Huang; Qi-Yi Zhao; Li-Li Wu; Dong-Ying Xie; Zhi-Liang Gao; Hong Deng
Journal:  Can J Gastroenterol Hepatol       Date:  2018-10-08

5.  Immune infiltration in renal cell carcinoma.

Authors:  Shichao Zhang; Erdong Zhang; Jinhua Long; Zuquan Hu; Jian Peng; Lina Liu; Fuzhou Tang; Long Li; Yan Ouyang; Zhu Zeng
Journal:  Cancer Sci       Date:  2019-04-07       Impact factor: 6.716

6.  Functionally impaired follicular helper T cells induce regulatory B cells and CD14+ human leukocyte antigen-DR- cell differentiation in non-small cell lung cancer.

Authors:  Liannv Qiu; Qinhua Yu; Yonglie Zhou; Sujie Zheng; Jiaojiao Tao; Qian Jiang; Guorong Yuan
Journal:  Cancer Sci       Date:  2018-11-14       Impact factor: 6.716

Review 7.  STAT3, a Master Regulator of Anti-Tumor Immune Response.

Authors:  Cédric Rébé; François Ghiringhelli
Journal:  Cancers (Basel)       Date:  2019-08-30       Impact factor: 6.639

Review 8.  TH1-Polarized TFH Cells Delay Naturally-Acquired Immunity to Malaria.

Authors:  Xi Zen Yap; Lucie S P Hustin; Robert W Sauerwein
Journal:  Front Immunol       Date:  2019-05-17       Impact factor: 7.561

9.  Gender Bias in Human Systemic Lupus Erythematosus: A Problem of Steroid Receptor Action?

Authors:  Virginia Rider; Nabih I Abdou; Bruce F Kimler; Nanyan Lu; Susan Brown; Brooke L Fridley
Journal:  Front Immunol       Date:  2018-03-28       Impact factor: 7.561

10.  Altered circulating T follicular helper cells in patients with chronic immune thrombocytopenia.

Authors:  Lan Dai; Linyan He; Zhaoyue Wang; Xia Bai; Yang He; Lijuan Cao; Mingqing Zhu; Changgeng Ruan
Journal:  Exp Ther Med       Date:  2018-07-23       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.